Joia M. Johnson
Joia M. Johnson's purchase track record
Joia M. Johnson has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/9/2026 | BRO | $50K | +15.3% | pending | — |
| 2/20/2026 | GPN | $99K | -10.9% | +14.2% | +11.1% |
| 3/11/2025 | RF | $49K | +7.8% | +30.6% | +16.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sylvamo Price Targets Lowered by BofA and Truist. Bank of America and Truist Securities recently lowered their price targets for Sylvamo, citing updated outlooks. While BofA maintains a Neutral rating with a $42 target, Truist keeps a Buy rating but reduced its target to $40. These adjustments place the new targets below the current average analyst estimate of $50.40, reflecting a more cautious view on the company's near-term valuation.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Regions Financial Reports Q3 Earnings Beat Estimates, Raises Dividend. Regions Financial posted Q3 earnings that surpassed analyst estimates, driven by higher net interest income and revenue growth year‑over‑year. The bank also lifted its quarterly dividend by 13%, though analysts note that future increases may be more difficult. While earnings remain solid, the company’s growth pace is modest, and the stock is currently near a key support level that has been tested multiple times.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BofA reinstates Global Payments coverage with $114 target. Bank of America has restarted coverage on Global Payments, issuing a buy rating and a price target of $114. This move places the stock within a broader wave of analyst actions affecting the payments sector, which also saw updates for FIS and Toast. The new target sits above the current average analyst estimate of $105.34, signaling renewed institutional interest in the company's outlook.
Transaction History
| BRO | ▲ Buy | Open Market | 860 | $50K | 6/9/2026 | View on chart |
| SLVM | ▲ Buy | Grant | 3,876 | $150K | 5/15/2026 | View on chart |
| BRO | ▲ Buy | Grant | 2,434 | $0 | 5/6/2026 | View on chart |
| RF | ▲ Buy | Option Exercise | 7,904 | $0 | 5/6/2026 | View on chart |
| GPN | ▲ Buy | Grant | 3,179 | $0 | 5/1/2026 | View on chart |
| GPN | ▲ Buy | Open Market | 1,213 | $99K | 2/20/2026 | View on chart |
| SLVM | ▲ Buy | Grant | 2,655 | $150K | 5/15/2025 | View on chart |
| GPN | ▲ Buy | Grant | 3,173 | $0 | 4/25/2025 | View on chart |
| RF | ▲ Buy | Option Exercise | 7,089 | $0 | 4/16/2025 | View on chart |
| RF | ▲ Buy | Open Market | 2,300 | $49K | 3/11/2025 | View on chart |
| SLVM | ▲ Buy | Grant | 1,779 | $125K | 5/16/2024 | View on chart |
| GPN | ▲ Buy | Grant | 1,846 | $0 | 4/26/2024 | View on chart |
| RF | ▲ Buy | Option Exercise | 7,460 | $0 | 4/17/2024 | View on chart |
| SLVM | ▲ Buy | Grant | 2,963 | $0 | 5/16/2023 | View on chart |
| GPN | ▲ Buy | Grant | 1,952 | $0 | 4/28/2023 | View on chart |
| SLVM | ▲ Buy | Grant | 2,623 | $0 | 5/16/2022 | View on chart |
| GPN | ▲ Buy | Grant | 1,606 | $220K | 4/29/2022 | View on chart |
| RF | ▲ Buy | Option Exercise | 5,276 | $0 | 4/20/2022 | View on chart |
| SLVM | ▲ Buy | Grant | 2,809 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Brown & Brown Faces Mixed Analyst Views on Valuation
Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.
Brown & Brown Faces Mixed Analyst Views on Valuation. Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.